Review of UK’s R&D tax relief system: implications for life sciences

UK life sciences businesses routinely engage in overseas research initiatives and clinical trials to inform the development of new medicines. That activity could fall outside the scope of the UK tax reliefs system for research and development (R&D) under potential reforms the UK government is considering.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.